labetuzumab govitecan

Ligand id: 8252

Name: labetuzumab govitecan

References
1. Govindan SV, Gale JB, Holman NJ, Goldenberg DM. (2014)
Antibody-sn-38 immunoconjugates with a cl2a linker.
Patent number: US20140227180. Assignee: Immunomedics, Inc.. Priority date: 13/12/2012. Publication date: 14/08/2014.
2. Govindan SV, Moon S-J,Goldenberg DM. (2014)
Immunoconjugates with an intracellularly-cleavable linkage.
Patent number: US8759496. Assignee: Immunomedics, Inc.. Priority date: 13/12/2002. Publication date: 24/06/2014.